SUSMED,Inc. Statistics

Total Valuation

SUSMED,Inc. has a market cap or net worth of JPY 10.47 billion. The enterprise value is 5.93 billion.

Market Cap	10.47B
Enterprise Value	5.93B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

SUSMED,Inc. has 16.81 million shares outstanding. The number of shares has increased by 0.77% in one year.

Current Share Class	16.81M
Shares Outstanding	16.81M
Shares Change (YoY)	+0.77%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	43.25%
Owned by Institutions (%)	18.19%
Float	7.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.12
PB Ratio	2.32
P/TBV Ratio	2.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-20.89
EV / Sales	13.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 33.89

Current Ratio	33.89
Quick Ratio	33.51
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -6.15% and return on invested capital (ROIC) is -3.84%.

Return on Equity (ROE)	-6.15%
Return on Assets (ROA)	-3.66%
Return on Invested Capital (ROIC)	-3.84%
Return on Capital Employed (ROCE)	-6.28%
Revenue Per Employee	11.62M
Profits Per Employee	-7.28M
Employee Count	39
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

In the past 12 months, SUSMED,Inc. has paid 1.00 million in taxes.

Income Tax	1.00M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.43
52-Week Price Change	n/a
50-Day Moving Average	568.46
200-Day Moving Average	592.70
Relative Strength Index (RSI)	53.86
Average Volume (20 Days)	87,290

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SUSMED,Inc. had revenue of JPY 453.00 million and -284.00 million in losses. Loss per share was -16.93.

Revenue	453.00M
Gross Profit	443.00M
Operating Income	-284.00M
Pretax Income	-283.00M
Net Income	-284.00M
EBITDA	-279.00M
EBIT	-284.00M
Loss Per Share	-16.93

Full Income Statement

Balance Sheet

The company has 4.54 billion in cash and n/a in debt, giving a net cash position of 4.54 billion or 270.15 per share.

Cash & Cash Equivalents	4.54B
Total Debt	n/a
Net Cash	4.54B
Net Cash Per Share	270.15
Equity (Book Value)	4.51B
Book Value Per Share	268.41
Working Capital	4.47B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 97.79%, with operating and profit margins of -62.69% and -62.69%.

Gross Margin	97.79%
Operating Margin	-62.69%
Pretax Margin	-62.47%
Profit Margin	-62.69%
EBITDA Margin	-61.59%
EBIT Margin	-62.69%
FCF Margin	n/a

Dividends & Yields

SUSMED,Inc. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.77%
Shareholder Yield	-0.77%
Earnings Yield	-2.71%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SUSMED,Inc. has an Altman Z-Score of 41.17 and a Piotroski F-Score of 3.

Altman Z-Score	41.17
Piotroski F-Score	3